SJS Investment Consulting
KMTS icon

SJS Investment Consulting’s Kestra Medical Technologies KMTS Stock Holding History

SJS Investment Consulting’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$567K Hold
20,060
– – 0.06% 86
2026
Q2 		$510K Buy
+20,060
New +$420K 0.06% 89

Other funds holding KMTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Next Century Growth Investors
Next Century Growth Investors Plymouth, Minnesota $1.57B AUM 96.5% 1-Year Est. Return

SJS Investment Consulting's KMTS Position: Q3 2026 in Review

SJS Investment Consulting held its Kestra Medical Technologies (KMTS) position steady in Q3 2026 at 20,060 shares worth $567K. The position accounts for 0.06% of the portfolio, ranked #86.

SJS Investment Consulting first reported a position in KMTS in Q2 2026 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold KMTS as of Q3 2026.

  • SJS Investment Consulting held 20,060 shares of Kestra Medical Technologies worth $567K as of Q3 2026.
  • SJS Investment Consulting left its Kestra Medical Technologies share count unchanged in Q3 2026.
  • Kestra Medical Technologies made up 0.06% of SJS Investment Consulting's portfolio in Q3 2026, its #86 holding.
  • SJS Investment Consulting first reported a position in Kestra Medical Technologies in Q2 2026 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.